Patisiran, an RNAi Therapeutic, for Hereditary Transthyretin Amyloidosis

Title
Patisiran, an RNAi Therapeutic, for Hereditary Transthyretin Amyloidosis
Authors
Keywords
-
Journal
NEW ENGLAND JOURNAL OF MEDICINE
Volume 379, Issue 1, Pages 11-21
Publisher
New England Journal of Medicine (NEJM/MMS)
Online
2018-07-05
DOI
10.1056/nejmoa1716153

Ask authors/readers for more resources

Find Funding. Review Successful Grants.

Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.

Explore

Publish scientific posters with Peeref

Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.

Learn More